Search Results - "van Spil, Willem E"

Identifying multivariate disease trajectories and potential phenotypes of early knee osteoarthritis in the CHECK cohort by Altamirano, Sara, Jansen, Mylène P, Oberski, Daniel L, Eijkemans, Marinus J C, Mastbergen, Simon C, Lafeber, Floris P J G, van Spil, Willem E, Welsing, Paco M J

“…To gain better understanding of osteoarthritis (OA) heterogeneity and its predictors for distinguishing OA phenotypes. This could provide the opportunity to…”
Get full text

Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines by Jeremiasse, Bernadette, Matta, Csaba, Fellows, Christopher R, Boocock, David J, Smith, Julia R, Liddell, Susan, Lafeber, Floris, van Spil, Willem E, Mobasheri, Ali

“…Chondrocytes are exposed to an inflammatory micro-environment in the extracellular matrix (ECM) of articular cartilage in joint diseases such as osteoarthritis…”
Get full text

Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis by van Spil, Willem E, Drossaers-Bakker, K Wiepke, Lafeber, Floris P J G

“…CTX-II (C-terminal telopeptide of type II collagen) has been put forward as a marker of collagen type II degradation being part of osteoarthritis. In this…”
Get more information

Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers by van Helvoort, Eefje M, van Spil, Willem E, Jansen, Mylène P, Welsing, Paco M J, Kloppenburg, Margreet, Loef, Marieke, Blanco, Francisco J, Haugen, Ida K, Berenbaum, Francis, Bacardit, Jaume, Ladel, Christoph H, Loughlin, John, Bay-Jensen, Anne C, Mobasheri, Ali, Larkin, Jonathan, Boere, Janneke, Weinans, Harrie H, Lalande, Agnes, Marijnissen, Anne C A, Lafeber, Floris P J G

“…The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (APPROACH) consortium intends to prospectively describe in detail, preselected…”
Get full text

What is the value of biomarkers for drug development in osteoarthritis? by Lotz, Martin, Martel-Pelletier, Johanne, Christiansen, Claus, Berenbaum, Francis, Brandi, Maria Luisa, Bruyère, Olivier, Chapurlat, Roland, COLLETTE, Julien, Cooper, Cyrus, Heinegard, Dick, Kanis, John A, Kraus, V, Laslop, Andrea, Lems, Willem, Lohmander, S, Meulenbelt, I, Pelletier, Jean-Pierre, Raynauld, Jean-Pierre, Reiter, Susan, Rizzoli, René, Sandel, L, Spector, Tim, Van Spil, Willem E, Reginster, Jean-Yves

Get full text